Cure8 research brief
Systemic glucocorticoids used for UC can cause bone loss; identifying early, noninvasive markers could let clinicians detect steroid-induced osteoporosis sooner and intervene to reduce fracture risk.
Clinicians treating UC patients on systemic steroids; researchers in bone biology and biomarkers; patients on or facing prolonged steroid therapy.
This study examined laboratory monitoring for bone loss in adults with moderate, relapsing ulcerative colitis treated with systemic glucocorticoids (1 mg/kg/day up to 12 weeks).
Researchers measured multiple bone turnover markers in blood, urine, and gingival fluid and found that cathepsin K activity in gingival fluid and serum sRANKL were early indicators of increased bone resorption during steroid therapy.
The authors propose a noninvasive monitoring approach using enzyme immunoassay measurement of cathepsin K in gingival fluid to help detect steroid-induced osteoporosis earlier. They also identified baseline blood TNF-α, gingival cathepsin K, and post-course serum sRANKL as predictors of higher osteoporosis risk on maintenance steroids.
These findings are presented as results from a single clinical study of 205 patients; the abstract-level source does not include long-term outcomes or external validation. Clinical adoption would require validation in other cohorts and practical assessment of assay availability and thresholds.
Summary is based on the article abstract provided by the journal (structured content depth: abstract). The findings come from one clinical cohort and require external validation and practical evaluation of gingival cathepsin K assays before routine clinical use.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The 1955 Truelove and Witts criteria do not account for patients already on modern outpatient therapies. Updated consensus criteria could change how ASUC is recognized and triaged in current clinical practice.
A nationwide clinician survey identifies major variation in how acute severe ulcerative colitis is diagnosed, monitored, and when rescue therapy or surgery is used — differences that can affect patient outcomes and...
GI infections—especially CMV—were common in this study and much more frequent in acute severe UC than in remission, suggesting testing for infections can change diagnosis and management during severe flares.
